视黄醇棕榈酸酯

综述指出视黄醇棕榈酸酯有潜在皮肤刺激，但缺乏高质量临床试验证据，且纳米制剂可能降低刺激

The review indicates that retinyl palmitate has potential for skin irritation, but lacks high-quality clinical trial evidence, and nanoformulations may reduce irritation.

视黄醇棕榈酸酯醇质体水凝胶在临床中表现出无或极轻微皮肤刺激，耐受性优于维A酸

Retinyl palmitate ethosomal hydrogel showed no or minimal skin irritation in clinical study, with better tolerability than tretinoin.

文献未研究皮肤刺激，仅提及传统递送有刺激，但本研究未进行刺激评估

The study did not investigate skin irritation; it only mentioned that conventional delivery causes irritation, but no irritation assessment was performed.

该研究比较维生素A（视黄醇棕榈酸酯）滴眼液与环孢素A治疗干眼症，未报告眼刺激，且维生素A组症状改善，表明无眼刺激风险。

This study compared vitamin A (retinyl palmitate) eye drops with cyclosporine A for dry eye disease, reported no ocular irritation, and vitamin A group showed symptom improvement, indicating no ocular irritation risk.

该研究评估视黄醇棕榈酸酯对兔角膜伤口愈合的影响，未报告眼刺激，且与对照组无差异，表明无眼刺激风险。

This study evaluated retinyl palmitate on rabbit corneal wound healing, reported no ocular irritation, and no difference from control, indicating no ocular irritation risk.

含RP的AVO-OMC组合显示光毒性潜力，但EHMCR可降低其光毒性

Combination AVO-OMC with RP showed phototoxic potential, but EHMCR reduced phototoxicity

RP作为纳米胶囊核心成分，仅在很高浓度下显示细胞毒性，未专门研究光毒性，且主要关注纳米胶囊的递送性能

RP as nanocapsule core showed cytotoxicity only at high concentrations; phototoxicity not specifically studied, focus on delivery performance

仅讨论光分解和光毒性机制，未提供直接实验证据证实RP的光毒性风险

Only discusses photodecomposition and phototoxicity mechanisms, no direct experimental evidence confirming phototoxicity risk of RP

证实RP在UVA+可见光照射下诱导DNA损伤和细胞毒性，浓度≥100 μM时细胞死亡显著

Confirms that RP induces DNA damage and cytotoxicity under UVA+visible light, with significant cell death at concentrations ≥100 μM

综述类文章，未提供原始实验数据证实RP的光毒性

Review article, no original experimental data confirming phototoxicity of RP

临床测试证实纳米颗粒（含视黄醇棕榈酸酯）无致痘性，但成分仅为混合物之一，非单独测试

Clinical tests confirmed the nanoparticles (containing retinyl palmitate) were not comedogenic, but the ingredient was only one component of the mixture, not tested alone.

研究检测到棕榈酸视黄酯存在于蓝藻中，但未涉及人体或动物暴露，不直接支持化妆品外用风险。

Study detects retinyl palmitate in cyanobacteria, but no human or animal exposure data; not directly relevant to topical cosmetic use.

高剂量维生素A（棕榈酸视黄酯）导致胚胎死亡率增加，但未观察到骨骼畸形，且暴露途径为饲料口服。

High-dose vitamin A (retinyl palmitate) increased embryonic mortality but no skeletal malformations; route is dietary oral.

体外实验显示棕榈酸视黄酯的代谢物联合作用增加致畸频率，但暴露途径为直接添加至培养基。

In vitro study shows combined metabolites of retinyl palmitate increase teratogenicity, but exposure is direct to culture medium.

综述提及高剂量维生素A有致畸风险，但未提供棕榈酸视黄酯的具体实验数据，且暴露途径为口服高剂量。

Review mentions teratogenicity risk of high-dose vitamin A, but no specific data on retinyl palmitate; route is oral high dose.

兔口服棕榈酸视黄酯后胚胎中全反式维A酸浓度升高，提示致畸风险，但暴露途径为口服高剂量。

Oral retinyl palmitate in rabbits increased embryonic all-trans-retinoic acid, indicating teratogenic risk, but route is oral high dose.

口服补充剂后血浆中致畸代谢物全反式维A酸浓度升高，但暴露途径为口服高剂量，非外用。

Oral supplements increased plasma levels of teratogenic metabolite all-trans-retinoic acid, but route is oral high dose, not topical.

大鼠口服棕榈酸视黄酯后观察到胚胎毒性，但剂量较高（约75 mg/kg/day），且暴露途径为口服，非外用。

Oral administration of retinyl palmitate in rats resulted in embryotoxicity at high doses (~75 mg/kg/day), but the route is oral, not topical.

体外实验显示视黄醇（维生素A）具有致畸性和生长抑制作用，但暴露途径为直接添加至培养基，非外用。

In vitro study shows retinol (vitamin A) is teratogenic and growth-retarding, but exposure is direct to culture medium, not topical.

该文研究纳米结构脂质载体递送棕榈酸视黄酯，未涉及安全终点。

This study focuses on nanostructured lipid carriers for retinyl palmitate delivery, not safety endpoints.

该文研究视黄醇和棕榈酸视黄酯作为渗透增强剂，未评估其自身的安全风险。

This study investigates retinol and retinyl palmitate as penetration enhancers, not their own safety risks.

该文研究壳聚糖纳米胶囊包裹棕榈酸视黄酯的稳定性和功效，未评估皮肤刺激或致敏。

This study investigates chitosan nanocapsules for retinyl palmitate delivery, not skin irritation or sensitization.

该文比较不同维A酸酯的代谢和生物活性，未涉及皮肤刺激或致敏等安全终点。

This study compares metabolism and bioactivity of retinoid esters, not skin irritation or sensitization.

该文研究果胶稳定化对棕榈酸视黄酯皮肤沉积的影响，未涉及安全终点。

This study examines the effect of pectin stabilization on skin deposition of retinyl palmitate, not safety endpoints.

该文研究共药抗坏血酸视黄酯的合成和皮肤渗透，棕榈酸视黄酯仅作为对照，未评估其安全风险。

This study focuses on synthesis and skin penetration of retinyl ascorbate co-drug; retinyl palmitate is used as a control, not for safety assessment.

该文研究外用维A酸类（包括棕榈酸视黄酯）的皮肤渗透和代谢，未评估皮肤刺激或致敏等安全终点。

This study investigates skin penetration and metabolism of topical retinoids including retinyl palmitate, without assessing skin irritation or sensitization.

该文研究棕榈酸视黄酯的经皮吸收和代谢，未涉及皮肤刺激或致敏等安全风险，仅关注代谢途径和渗透量。

This study focuses on percutaneous absorption and metabolism of retinyl palmitate, not on skin irritation or sensitization safety endpoints.